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122a Sunday, February 8, 2015domain, which encompasses a conserved heme regulatory motif (HRM,
612CKACH616 (Tang et al., Nature 2003) and endows BK channels with
catalytic properties (Yusifov et al., Biophys J 2710-Pos 2014). Alignment
of the BK Cytochrome-c-like domain and the human Cytochrome C
(CytC) sequences revealed that they share, in addition to the HRM, key
structural and functional elements. Notably, Met-80 in CytC, which is the
second axial ligand to the heme iron, aligns with BK Met-691. In fact, mu-
tation M691A dramatically reduced the Heme-dependent peroxidase activity
of the purified BK channel Gating Ring. We assessed the involvement M691
in the heme modulation of BK channel conducting properties by inside-out
patch clamp in WT and M691A channels expressed in Xenopus oocytes. The
Kþ current from WT BK channels was reduced by 61.6514.6% (140mV) in
100nM heme. On the contrary, under identical conditions, Kþ current was
reduced by only 13.252.23% in BK channels carrying the M691A muta-
tion. Moreover, the conductance half-activation potential (Vhalf) of WT
BK shifted from 81.253.03 to 12651.67mV after the addition of 100nM
heme. Conversely, in M691A channels, the Vhalf was largely unperturbed
by 100nM heme (from 98.254.13 to 10058.76mV). Thus, M691A essen-
tially eliminated the BK channel sensitivity to heme. These results reinforce
the view that a Cytochrome-c-like domain, which associates heme via
the HRM and a second axial ligand (Met-691) is an integral part of BK
channels.
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Carbon monoxide (CO) is a recognized gasotransmitter that regulates BK chan-
nel activity, causing vasodilatory effects. It is thought that CO interacts with the
intracellular portion of BK channels, which consists of the assembly of struc-
tural domains RCK1 and RCK2 into the ligand-sensing Gating Ring superstruc-
ture. Several mechanisms have been proposed to account for the BK/CO
interaction (Heinemann et al., Chem Commun 2014). We have tested the hy-
pothesis that CO interacts with BK channels via heme, which associates with
the RCK1-RCK2 linker region, previously described as the BK Cytochrome-
c-like domain (Yusifov et al., Biophysical J, 2709-Pos 2014). We investigated
the molecular interaction of CO with the purified human BK channel Gating
Ring using absorption spectroscopy: we found that the spectrum of the Gating
Ring complexed with the reduced form of heme [Fe(II) protoporphyrin-IX] was
significantly altered in the presence of CO and produced a Soret peak at 422 nm
and b/a bands at 538 and 574 nm, typical spectral characteristic of hemopro-
teins complexed with CO. Furthermore, CO-dependent conformational
changes were assessed using ANS (8-Anilino-1-naphthalenesulfonic acid) fluo-
rescence spectra of the Gating Ring/reduced heme complex in the presence of
increasing [CO]. The intensity of GR/ANS emission diminished in a [CO]-
dependent manner (K0.5¼5453.8nM), indicating less ANS association, and
therefore the occurrence of CO-dependent GR structural rearrangements. On
the contrary, when heme was substituted by protoporphyrin-IX, a heme analog
that lacks iron, CO addition did not alter ANS fluorescence. These results sug-
gest that, in BK channels, the Heme/Cytochrome-c-like domain complex acts
as a CO sensor, binding CO via heme and inducing a conformational change
to the BK channel Gating Ring at submicromolar [CO]. This structural transi-
tion likely represents one of the mechanisms underlying the CO-dependent
regulation of the human BK channel.
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High-conductance Ca(2þ)-and voltage-activated K(þ) (Slo1 or BK) channels
play key roles in many normal and pathophysiological processes, such as
sinoatrial node pacing, blood pressure regulation, neurotransmitter release,
autism, and epilepsy. The Slo1 channel can be divided into a trans-
membrane core module comprised of the pore gate domain (PGD) surrounded
by four voltage sensor (VS domains), and a large cytosolic domain (CTD)
which forms an intracellular gating ring. DHA (docosahexaenoic acid), pro-
tons, and DiBAC4(3) (bis-(1,3-dibutylbarbituric acid) trimethine oxonol)
can activate wt BK channels. Our construct of functional Slo1-core channelscomprised of the PGD and VS domains without the CTD provides a tool to
explore drug target domains of BK channels. In this study, we test the action
of DHA, protons, and DiBac4(3) on wt and Slo1-core channels using single-
channel and macro-patch recordings to measure channel activity before and
after application of activating agents. We found that both DHA and Di-
BAC4(3) activate Slo1-core channels. This was the case with or without
beta1 subunits. These results indicate that DHA and DiBAC4(3) do not
require the CTD to activate Slo1 channels. We also found that protons did
not activate Slo1-core channels, which directly shows that protons require
the CTD for their action, while having little or no direct action on the core
of the channel. Our results for DHA and protons are consistent with previous
studies using less direct experimental approaches. Our observation that Di-
BAC4(3) can activate core channels in the absence of the gating ring is a
novel. This study is a clear demonstration of the utility of the functional
Slo1-core constructs we have developed for locating the sites of action of
BK channel enhancers and modulators.
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By opening and closing a potassium-selective ion permeation pathway in
response to changes of transmembrane potential or intracellular Ca2þ concen-
tration, the BK-type potassium channels serve key roles in many important
physiological processes. To probe conformational changes associated with
gating, we engineered two Cd2þ coordination sites by cysteine substitution
of BK inner pore residues in the S6 inner helix. The first coordination site is
formed by A316C, a pore lining residue located deep inside the BK inner
pore region. Intracellularly applied Cd2þ binds to this site with modest
state-dependence, suggesting that the cytosolic entrance of BK channel does
not significantly occlude metal ion flow even in the closed state. The second
Cd2þ coordination site is formed by V319C, which is in the middle of the
YVP motif (equivalent to Kv PXP motif) near the cytosolic entrance of BK
channel. State-dependence of Cd2þ-V319C coordination is very weak, indi-
cating that the structure of this coordination site remains stable during BK
channel gating. More importantly, our results show that Cd2þ-V319C coordi-
nation involves a native glutamate (E321) from same subunit, which suggests
that the distance between the side chains of V319C and E321 is much shorter
than that observed in Kv channel structures. This result suggests that the
conserved proline in the YVP motif introduces a kink in BK S6 that is sharper
than that observed in Kv channel structures.
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GoSlo-SR-5-6 (GoSlo) is a novel BK channel agonist that shifts the activation
V1/2 of BK channels by >-100 mV when applied at a concentration of 10mM
concentration. Although the structure-activity relationships of the GoSlo-SR
channel agonists has been studied extensively [1], nothing is known about their
mode of action.
GoSlo was as effective on Slo1 a subunits as it was on BK channels from
the rabbit bladder smooth muscle and shifted V1/2 > 100 mV. Similarly,
GoSlo shifted activation V1/2 >-100 mV in truncated BK channels [2]. Its
effects were reduced >50% in the Slo1_9a splice variant [3] and in chi-
meras containing Slo1_9a S6 sequence. Of the three residues that differ
in S6 between Slo1 and Slo1_9a, only the S317R mutant reduced the effects
of GoSlo. We identified two other residues (L227A in S4/S5 linker and
I326A in S6) that, when mutated to alanine, also diminished the effects
of GoSlo significantly. A triple mutation (L227A:S317R:I326A) virtually
abolished the effects of GoSlo (DV1/2 -1554 mV, n¼11). To investigate
the mechanism of action of GoSlo, we used the HA allosteric model [4].
Our data suggests that SR-5-6 interacts with the transmembrane segment
of the channel to enhance pore opening by stabilising the open state
(L0~700 fold), activating the voltage sensors (J0~8 fold), but interestingly
reducing allosteric coupling between the voltage sensors and pore gate
(D) ~60%.
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